GW Pharmaceuticals, the English drug maker planning a U.S. initial public offering, is working with outside communications counsel and hired a U.S.-based PR and investor relations exec.GW Adds US IR Exec Ahead of IPO
Wed., Mar. 20, 2013
By Greg Hazley
GW Pharmaceuticals, the English drug maker planning a U.S. initial public offering, is working with outside communications counsel and hired a U.S.-based PR and investor relations exec.Read Full Story in Subscriber Area
Category: Financial PR & Investor Relations
More Financial PR & Investor Relations posts from O'Dwyer's:
| • | Edelman Sails with VikingMon., Apr. 22, 2024
|
Edelman handles Viking Holdings, the river and ocean luxury cruise line that plans to raise $1B via an IPO priced in the $21 to $25 per share range.| • | Teneo Handles CVC Capital’s IPOMon., Apr. 15, 2024
|
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.| • | Brunswick, Edelman Smithfield Work Endeavor’s $13B DealWed., Apr. 3, 2024
|
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.| • | Donhauser Takes Helm of H/Advisors Abernathy's SF UnitMon., Mar. 25, 2024
|
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.| • | Intelligent Group IR Firm Lists on NASDAQWed., Mar. 20, 2024
|
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Have a comment? Send it to 
No comments have been submitted for this story yet.